Neuromelanin and T(2)*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease

MRI was suggested as a promising method for the diagnosis and assessment of Parkinson’s Disease (PD). We aimed to assess the sensitivity of neuromelanin-MRI and T(2)* with radiomics analysis for detecting PD, identifying individuals at risk, and evaluating genotype-related differences. Patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben Bashat, Dafna, Thaler, Avner, Lerman Shacham, Hedva, Even-Sapir, Einat, Hutchison, Matthew, Evans, Karleyton C., Orr-Urterger, Avi, Cedarbaum, Jesse M., Droby, Amgad, Giladi, Nir, Mirelman, Anat, Artzi, Moran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586960/
https://www.ncbi.nlm.nih.gov/pubmed/36271084
http://dx.doi.org/10.1038/s41531-022-00405-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586960/
https://www.ncbi.nlm.nih.gov/pubmed/36271084
http://dx.doi.org/10.1038/s41531-022-00405-9

Ejemplares similares